Maturation pathways of dendritic cells determine TAP1 and TAP2 levels and cross-presenting function

Journal of Immunotherapy

Volumn 32, Issue 5, 2009, Pages 465-473

  López Albaitero, Andrés ^a   Mailliard, Robbie ^a   Hackman, Trevor ^a   Filho, Pedro A Andrade ^a   Wang, Xinhui ^a   Gooding, William ^a   Ferrone, Soldano ^a   Kalinski, Pawel ^a   Ferris, Robert L ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Antigen processing presentation; Dendritic cells; Vaccination

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN; PROSTAGLANDIN E2; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL MATURATION; CELL STIMULATION; CONTROLLED STUDY; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; ATP-BINDING CASSETTE TRANSPORTERS; CANCER VACCINES; CARCINOMA, SMALL CELL; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CYTOKINES; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HLA-A ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MELANOMA; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; PROSTAGLANDINS;

EID: 67651163510     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e3181a1c24e     Document Type: Article

References (22)

1. Lin C, Grandis JR, Carey TE, et al. Lai Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head and Neck. 2007;29:163-188
2. Salter RD, Cresswell P. Impaired assembly and transport of HLA-A and HLA-B antigens in a mutant TxB cell hybrid. EMBO J. 1986;5:943-949.
3. Parham PBC, Bodmer WF. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A, B, C, antigens. J Immunol. 1979;123:342-349.
4. Parham PBW. Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2. Nature. 1978;276:397-399.
5. Lampson LA, Levy R. Two populations of Ia-like molecules on a human B cell line. J Immunol. 1980;125:293-299.
6. Bandoh N, Ogino T, Cho HS, et al. Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies. Tissue Antigens. 2005;66:185-194.
7. Barnstable CJ, Bodmer WF, Brown G, et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell. 1978;14:9-20.
8. Temponi M, Kekish U, Hamby CV, et al. Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues. J Immunol Methods. 1993;161:239-256.
9. Ogino T, Wang X, Kato S, et al. Endoplasmic reticulum chaperone-specific monoclonal antibodies for flow cytometry and immunohistochemical staining. i. 2003;62:385-393.
10. Wang X, Campoli M, Cho HS, et al. A method to generate antigen-specific mAb capable of staining formalin-.xed, paraffin-embedded tissue sections. J Immunol Methods. 2005; 299:139-151.
11. Gaugler B, Van den Eynde B, van der Bruggen P, et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med. 1994; 179:921-930.
12. Ogino T, Wang X, Ferrone S. Modified flow cytometry and cell-ELISA methodology to detect HLA class I antigen processing machinery components in cytoplasm and endoplasmic reticulum. J Immunol Methods. 2003;278:33-44.
13. Lopez-Albaitero A, Nayak JV, Ogino T, et al. Role of antigenprocessing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL. J Immunol. 2006;176:3402-3409.
14. Mailliard RB, Wankowicz-Kalinska A, Cai Q, et al. alphatype-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res. 2004;64:5934-5937.
15. + T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res. 2004;10:6929-6937.
16. Jonuleit H, Kuhn U, Muller G, et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol. 1997;27:3135-3142.
17. Thumann P, Moc I, Humrich J, et al. Antigen loading of dendritic cells with whole tumor cell preparations. J Immunol Methods. 2003;277:1-16.
18. Frasca L, Nasso M, Spensieri F, et al. IFN-gamma arms human dendritic cells to perform multiple effector functions. J Immunol. 2008;180:1471-1481.
19. Lou Y, Basha G, Seipp RP, et al. Combining the antigen processing components tap and tapasin elicits enhanced tumorfree survival. Clin Cancer Res. 2008;14:1494-1501.
20. Vitalis TZ, Zhang QJ, Alimonti J, et al. Using the TAP component of the antigen-processing machinery as a molecular adjuvant. PLoS pathogens. 2005;1:e36.
21. Zwaveling S, Ferreira Mota SC, Nouta J, et al. Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides. J Immunol. 2002;169:350-358.
22. Huang AY, Bruce AT, Pardoll DM, et al. In vivo crosspriming of MHC class I-restricted antigens requires the TAP transporter. Immunity. 1996;4:349-355.